Cargando…

Finding Fusin/CXCR4, the First “2nd Receptor” for HIV Entry

Detalles Bibliográficos
Autor principal:	Berger, Edward A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459226/ https://www.ncbi.nlm.nih.gov/pubmed/26106389 http://dx.doi.org/10.3389/fimmu.2015.00283

Ejemplares similares

CXCR4/fusin Is Not a Species-specific Barrier in Murine Cells for HIV-1 Entry
por: Tachibana, Kazunobu, et al.
Publicado: (1997)

Focused ultrasound-mediated intranasal brain drug delivery technique (FUSIN)
por: Ye, Dezhuang, et al.
Publicado: (2021)

The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration
por: Bianchi, Marco E., et al.
Publicado: (2020)

Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation
por: Ngamsri, Kristian-Christos, et al.
Publicado: (2020)

Isotype Specific Assembly of B Cell Antigen Receptors and Synergism With Chemokine Receptor CXCR4
por: Maity, Palash C., et al.
Publicado: (2018)

AMD3100/CXCR4 Inhibitor
por: De Clercq, Erik
Publicado: (2015)

Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives
por: Pawig, Lukas, et al.
Publicado: (2015)

Targeting the chemokine receptor CXCR4 with histamine analog to reduce inflammation in juvenile arthritis
por: Bekaddour, Nassima, et al.
Publicado: (2023)

The orally bioavailable allosteric CXCR4 HIV-1 entry inhibitor AMD11070
por: Fricker, Simon, et al.
Publicado: (2012)

Editorial: The CXCR4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients
por: Noels, Heidi, et al.
Publicado: (2016)

Dichotomous Roles of Programmed Cell Death 1 on HIV-Specific CXCR5(+) and CXCR5(−) CD8(+) T Cells during Chronic HIV Infection
por: Jiao, Yan-Mei, et al.
Publicado: (2017)

CXCL12/SDF-1 and CXCR4
por: Nagasawa, Takashi
Publicado: (2015)

The Structure of a CXCR4:Chemokine Complex
por: Handel, Tracy Marie
Publicado: (2015)

Coexpression of CCR7 and CXCR4 During B Cell Development Controls CXCR4 Responsiveness and Bone Marrow Homing
por: Mcheik, Saria, et al.
Publicado: (2019)

Development of an anti-CAR antibody response in SIV-infected rhesus macaques treated with CD4-MBL CAR/CXCR5 T cells
por: Davey, Brianna C., et al.
Publicado: (2022)

Mimicking Protein–Protein Interactions through Peptide–Peptide Interactions: HIV-1 gp120 and CXCR4
por: Groß, Andrea, et al.
Publicado: (2013)

Pleiotropic Roles of CXCR4 in Wound Repair and Regeneration
por: Chen, Huating, et al.
Publicado: (2021)

CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice
por: Mattos, Matheus Silverio, et al.
Publicado: (2020)

CXCR2: From Bench to Bedside
por: Stadtmann, Anika, et al.
Publicado: (2012)

Blood CXCR3(+) CD4 T Cells Are Enriched in Inducible Replication Competent HIV in Aviremic Antiretroviral Therapy-Treated Individuals
por: Banga, Riddhima, et al.
Publicado: (2018)

Flavivirus Receptors: Diversity, Identity, and Cell Entry
por: Laureti, Mathilde, et al.
Publicado: (2018)

A Novel CXCR4 Targeting Protein SDF-1/54 as an HIV-1 Entry Inhibitor
por: Tan, Suiyi, et al.
Publicado: (2019)

Structural Insights Into How Proteoglycans Determine Chemokine-CXCR1/CXCR2 Interactions: Progress and Challenges
por: Rajarathnam, Krishna, et al.
Publicado: (2020)

Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury
por: Piotrowska, Anna, et al.
Publicado: (2019)

Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore‐based virtual screening approach
por: Mirza, Muhammad Usman, et al.
Publicado: (2020)

Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages
por: De Santis, Federica, et al.
Publicado: (2022)

Divergent Expression of CXCR5 and CCR5 on CD4(+) T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection
por: Zaunders, John, et al.
Publicado: (2017)

Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer
por: Eckert, Franziska, et al.
Publicado: (2018)

In and Out of the Bursa—The Role of CXCR4 in Chicken B Cell Development
por: Nagy, Nandor, et al.
Publicado: (2020)

Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
por: Litman-Zawadzka, Ala, et al.
Publicado: (2020)

Blockade of Neutrophil’s Chemokine Receptors CXCR1/2 Abrogate Liver Damage in Acute-on-Chronic Liver Failure
por: Khanam, Arshi, et al.
Publicado: (2017)

Plasmodium chabaudi AS Infection Induces CD4(+) Th1 Cells and Foxp3(+)T-bet(+) Regulatory T Cells That Express CXCR3 and Migrate to CXCR3 Ligands
por: Berretta, Floriana, et al.
Publicado: (2019)

Dipeptidyl Peptidase-4 Regulation of SDF-1/CXCR4 Axis: Implications for Cardiovascular Disease
por: Zhong, Jixin, et al.
Publicado: (2015)

Unique profile of predominant CCR5-tropic in CRF07_BC HIV-1 infections and discovery of an unusual CXCR4-tropic strain
por: Hu, Xiaoyan, et al.
Publicado: (2022)

The CXCL12/CXCR4 Signaling Axis Retains Neutrophils at Inflammatory Sites in Zebrafish
por: Isles, Hannah M., et al.
Publicado: (2019)

CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells
por: Fortunato, Orazio, et al.
Publicado: (2020)

Reduced CD4(+)T Cell CXCR3 Expression in Patients With Allergic Rhinitis
por: Yu, Xiaofeng, et al.
Publicado: (2020)

Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort
por: Fink, Elizabeth, et al.
Publicado: (2016)

The Antibody Receptor Fc Gamma Receptor IIIb Induces Calcium Entry via Transient Receptor Potential Melastatin 2 in Human Neutrophils
por: Alemán, Omar Rafael, et al.
Publicado: (2021)

Enhanced CXCR4 Expression of Human CD8(Low) T Lymphocytes Is Driven by S1P(4)
por: Burkard, Tobias, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i6dq0mqriu8g83bib4ac2lrrcl